As the data on the kinetic parameter and molecular docking supports the idea that pinocembrin inhibits hOAT1-mediated PAH uptake and hOAT3-mediated estrone sulfate uptake, the drug transporter inhibition mode could be a competitive mechanism. This evidence concerns the gene SLC22A8 and pulmonary arterial hypertension.